For the readers interested in the stock health of Antares Pharma Inc. (ATRS). It is currently valued at $2.94. When the transactions were called off in the previous session, Stock hit the highs of $3.03, after setting-off with the price of $2.84. Company’s stock value dipped to $2.82 during the trading on the day. When the trading was stopped its value was $3.00.
Recently in News on August 6, 2020, Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today reported operating and financial results for the second quarter ended June 30, 2020 with record second quarter revenue of $32.4 million and net income of $2.2 million, or earnings per share of $0.01. The Company also reported record six-month year-to-date revenue of $65.5 million, a 27% increase versus the first six months of 2019. You can read further details here
Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20.
Antares Pharma Inc. (ATRS) full year performance was -8.54%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Antares Pharma Inc. shares are logging -42.69% during the 52-week period from high price, and 83.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.60 and $5.13.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 993001 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Antares Pharma Inc. (ATRS) recorded performance in the market was -36.17%, having the revenues showcasing 10.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 510.00M, as it employees total of 178 workers.
Market experts do have their say about Antares Pharma Inc. (ATRS)
During the last month, 4 analysts gave the Antares Pharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.70, with a change in the price was noted +0.91. In a similar fashion, Antares Pharma Inc. posted a movement of +44.20% for the period of last 100 days, recording 1,266,804 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATRS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.75.
Technical breakdown of Antares Pharma Inc. (ATRS)
Raw Stochastic average of Antares Pharma Inc. in the period of last 50 days is set at 64.08%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 74.59%. In the last 20 days, the company’s Stochastic %K was 74.50% and its Stochastic %D was recorded 61.67%.
Bearing in mind the latest performance of Antares Pharma Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -36.17%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -21.88%, alongside a downfall of -8.54% for the period of the last 12 months. The shares increased approximately by 13.21% in the 7-day charts and went up by 11.11% in the period of the last 30 days. Common stock shares were driven by 10.70% during last recorded quarter.